CARLO STELLA, CARMELO

CARLO STELLA, CARMELO  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 243 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
[Mesenchymal stem cells: biology and clinical applications] 1-gen-2002 Carlo-Stella, Carmelo; Di Nicola, Massimo; Gianni, Massimo A
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 1-gen-2009 Righi, M.; Giacomini, A.; Lavazza, C.; Sia, D.; Carlo-Stella, C.; Gianni, A.
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 1-gen-2020 Carlo Stella, C; Delarue, R; Scarfo, L; Barde, Pj; Nair, A; Locatelli, Sl; Morello, L; Magagnoli, M; Vakkalanka, S; Viswanadha, S; Ferreri, Ajm
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma 1-gen-2019 Kahl, Bs; Hamadani, M; Radford, J; Carlo Stella, C; Caimi, P; Reid, E; Feingold, Jm; Ardeshna, Km; Solh, M; Heffner, Lt; Ungar, D; He, S; Boni, J; Havenith, K; O'Connor, Oa
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma 1-gen-2021 Balzarotti, Monica; Magagnoli, Massimo; Canales, Miguel Ángel; Corradini, Paolo; Grande, Carlos; Sancho, Juan-Manuel; Zaja, Francesco; Quinson, Anne-Marie; Belsack, Valérie; Maier, Daniela; Carlo-Stella, Carmelo
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling 1-gen-2018 Sarina, B; Mariotti, J; Bramanti, S; Morabito, L; Crocchiolo, R; Rimondo, A; Tordato, F; Pocaterra, D; Casari, E; De Philippis, C; Carlo Stella, C; Santoro, A; Castagna, L
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 1-gen-2009 Chiesa, C.; Botta, F.; Coliva, A.; Maccauro, M.; Devizzi, L.; Guidetti, A.; Carlo-Stella, C.; Seregni, E.; Gianni, A. M.; Bombardieri, E.
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION 1-gen-1993 Balduini, Cl; CARLO-STELLA, C.; Rosti, V; Bertolino, G; Noris, P; Ascari, E
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 1-gen-2004 Carlo-Stella, C.; Di Nicola, M.; Milani, R.; Longoni, P.; Milanesi, M.; Bifulco, C.; Stucchi, C.; Guidetti, A.; Cleris, L.; Formelli, F.; Garotta, G.; Gianni, A. M.
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome 1-gen-2020 Castagna, Luca; Pagliardini, Thomas; Bramanti, Stefania; Schiano de Colella, Jean Marc; Montes de Oca, Catalina; Bouabdallah, Reda; Mariotti, Jacopo; Fürst, Sabine; Granata, Angela; De Philippis, Chiara; Harbi, Samia; Sarina, Barbara; Legrand, Faezeh; Maisano, Valerio; Weiller, Pierre Jean; Chabannon, Christian; Carlo-Stella, Carmelo; Santoro, Armando; Blaise, Didier; Devillier, Raynier
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 1-gen-2021 Merryman, Reid W; Castagna, Luca; Giordano, Laura; Ho, Vincent T; Corradini, Paolo; Guidetti, Anna; Casadei, Beatrice; Bond, David A; Jaglowski, Samantha; Spinner, Michael A; Arai, Sally; Lowsky, Robert; Shah, Gunjan L; Perales, Miguel-Angel; De Colella, Jean Marc Schiano; Blaise, Didier; Herrera, Alex F; Shouse, Geoffrey; Spilleboudt, Chloe; Ansell, Stephen M; Nieto, Yago; Badar, Talha; Hamadani, Mehdi; Feldman, Tatyana A; Dahncke, Lori; Singh, Anurag K; Mcguirk, Joseph P; Nishihori, Taiga; Chavez, Julio; Serritella, Anthony V; Kline, Justin; Mohty, Mohamad; Dulery, Remy; Stamatoulas, Aspasia; Houot, Roch; Manson, Guillaume; Moles-Moreau, Marie-Pierre; Orvain, Corentin; Bouabdallah, Kamal; Modi, Dipenkumar; Ramchandren, Radhakrishnan; Lekakis, Lazaros; Beitinjaneh, Amer; Frigault, Matthew J; Chen, Yi-Bin; Lynch, Ryan C; Smith, Stephen D; Rao, Uttam; Byrne, Michael; Romancik, Jason T; Cohen, Jonathon B; Nathan, Sunita; Phillips, Tycel; Joyce, Robin M; Rahimian, Maryam; Bashey, Asad; Ballard, Hatcher J; Svoboda, Jakub; Torri, Valter; Sollini, Martina; De Philippis, Chiara; Magagnoli, Massimo; Santoro, Armando; Armand, Philippe; Zinzani, Pier Luigi; Carlo-Stella, Carmelo
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma 1-gen-2021 Munshi, Pashna N.; Hamadani, Mehdi; Kumar, Ambuj; Dreger, Peter; Friedberg, Jonathan W.; Dreyling, Martin; Kahl, Brad; Jerkeman, Mats; Kharfan-Dabaja, Mohamed A.; Locke, Frederick L.; Shadman, Mazyar; Hill, Brian T.; Ahmed, Sairah; Herrera, Alex F.; Sauter, Craig S.; Bachanova, Veronika; Ghosh, Nilanjan; Lunning, Matthew; Kenkre, Vaishalee P.; Aljurf, Mahmoud; Wang, Michael; Maddocks, Kami J.; Leonard, John P.; Kamdar, Manali; Phillips, Tycel; Cashen, Amanda F.; Inwards, David J.; Sureda, Anna; Cohen, Jonathon B.; Smith, Sonali M.; Carlo-Stella, Carmelo; Savani, Bipin; Robinson, Stephen P.; Fenske, Timothy S.
Amifostine (WR-2721) selective protection against melphalan genotoxicity 1-gen-2000 Buschini, A.; Anceschi, E.; Carlo-Stella, C.; Regazzi, E.; Rizzoli, V.; Poli, P.; Rossi, C.
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells 1-gen-2008 Carlo Stella, C.; Lavazza, C.; Carbone, A.; Gianni, A. M.
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL 1-gen-2007 Carlo Stella, C.; Lavazza, C.; Carbone, A.; Gianni, A. M.
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 1-gen-2006 Carlo-Stella, C.; Lavazza, C.; Di Nicola, M.; Cleris, L.; Longoni, P.; Milanesi, M.; Magni, M.; Morelli, D.; Gloghini, A.; Carbone, A.; Gianni, A. M.
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process 1-gen-1995 RIZZO M., T; BOSWELL S., H; Mangoni, L; CARLO-STELLA, C.; Rizzoli, V
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation sf the c-jun amino-terminal kinases in stromal cells 1-gen-1996 Rizzo, Mt; Carlo Stella, C.
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? 1-gen-2018 Carbone, A; Gloghini, A; Carlo Stella, C
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma 1-gen-2021 Munshi, Pashna N.; Hamadani, Mehdi; Kumar, Ambuj; Dreger, Peter; Friedberg, Jonathan W.; Dreyling, Martin; Kahl, Brad; Jerkeman, Mats; Kharfan-Dabaja, Mohamed A.; Locke, Frederick L.; Shadman, Mazyar; Hill, Brian T.; Ahmed, Sairah; Herrera, Alex F.; Sauter, Craig S.; Bachanova, Veronika; Ghosh, Nilanjan; Lunning, Matthew; Kenkre, Vaishalee P.; Aljurf, Mahmoud; Wang, Michael; Maddocks, Kami J.; Leonard, John P.; Kamdar, Manali; Phillips, Tycel; Cashen, Amanda F.; Inwards, David J.; Sureda, Anna; Cohen, Jonathon B.; Smith, Sonali M.; Carlo-Stella, Carmelo; Savani, Bipin; Robinson, Stephen P.; Fenske, Timothy S.